CLX vs SMMT · P/E 15, rev $7.10B vs $11.46B cap
The Clorox Company (CLX) versus Summit Therapeutics PLC (SMMT) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
SMMT does not have a complete income-statement cache yet.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. SMMT currently screens at market cap $11.46B.
Not investment advice. Open the CLX and SMMT stock pages for the full models.
Not investment advice.